Australia's largest stock trading and investment forum Australia's #1 stock forum

GMV

Click for more information

0.00%

3.9¢ g medical innovations holdings limited

Ann: G Medical Continues Rapid Growth in USA, page-136

First 136 Last

Share
Profile

Follow
Atlas712

274 Posts.

105

15/09/20

18:20

Post #: 47362613
Share

Originally posted by HonyakuKonyaku: ↑

Apologies if this has already been posted. If anyone has $3600 spare, they can download this report which seems to feature GMV quite prominently:

Strategies Deployed in 2020

Jul-2020: Biotricity signed partnership agreement with Verizon for developing EMS solutions for First Responders by integrating its Bioflux solution. Bioflux is a high-precision, single-unit mobile cardiac telemetry (MCT) device that provides real-time monitoring and transmission of patients' ECG information. Combining the Bioflux solution into Verizon's EMS platform fulfill an unmet need for First Responders, enabling them to access critical, potentially life-saving data in real-time and respond immediately in a crisis.

Apr-2020: Medicomp, Inc. partnered with New York based Lenox Hill Hospital, part of the Northwell Health system. Following the partnership, Lenox Hill Hospital will be using Medicomp's TelePatch mobile cardiac telemetry (MCT) monitor for measuring the heart's electrical conduction for abnormalities in patients that have been prescribed certain medications in the treatment of COVID-19.

Apr-2020: G Medical Innovations Holdings got FDA approval for its Prizma medical smartphone case. Prizma has been allowing consumers to turn their smartphone into a mobile medical monitor to measure a range of vital signs including temperature, heart rate, stress levels and blood oxygen saturation which can be used to detect symptoms associated with infection and chronic illness.

Key Topics Covered

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Mobile Cardiac Telemetry Systems Market, by Application
1.4.2 Global Mobile Cardiac Telemetry Systems Market, by End User
1.4.3 Global Mobile Cardiac Telemetry Systems Market, by Geography
1.5 Methodology for the Research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global
3.1 Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Approvals
3.2.4 Mergers & Acquisitions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2016-2020)
3.3.2 Key Strategic Move: (Acquisition and Mergers: 2017, Feb - 2019, Aug) Leading Players

Chapter 4. Global Mobile Cardiac Telemetry Systems Market by Application
4.1 Global Lead based Market by Region
4.2 Global Patch Based Market by Region

Chapter 5. Global Mobile Cardiac Telemetry Systems Market by End-user
5.1 Global Hospitals Market by Region
5.2 Global Cardiac centers Market by Region
5.3 Global Other End-user Market by Region

Chapter 6. Global Mobile Cardiac Telemetry Systems Market by Region
6.1 North America Mobile Cardiac Telemetry Systems Market
6.2 Europe Mobile Cardiac Telemetry Systems Market
6.3 Asia-Pacific Mobile Cardiac Telemetry Systems Market
6.4 LAMEA Mobile Cardiac Telemetry Systems Market

Chapter 7. Company Profiles
7.1 Hill-Rom Holdings, Inc. (Welch Allyn)
7.2 Asahi Kasei Corporation (Zoll Medical Corporation)
7.3 ScottCare Corporation (Berkshire Hathway, Inc.)
7.4 iRhythm Technologies, Inc.
7.5 Biotricity, Inc.
7.6 G Medical Innovations Holdings Ltd. (Telerhythmics LLC)
7.7 BioTelemetry, Inc.
7.8 Applied Cardiac Systems, Inc.
7.9 Medicomp, Inc.
7.10 Preventice Solutions, Inc.

For more information about this report visit https://www.researchandmarkets.com/r/4ltfez

Expand

yeah I saw this too but was confused that it mentioner prizma instead of patch so I disregarded it. definitely not spending $3600 on a document with that sort of attention to detail

GMV Price at posting: 3.4¢ Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

HVN

Harvey Norman may appeal ASIC Federal Court case – the third lawsuit on its plate

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

RCE

Recce reaches key dosing milestone in testing of skin infection gel

RBA holds rates as ALP election campaigning kicks off – expect more political focus

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

There are more pages in this discussion • 22 more messages in this thread...

First 136 Last

Add GMV (ASX) to my watchlist